Literature DB >> 1353488

Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.

J L Bidwell1, E A Bidwell, E Dupont, M Andrien, C Bouillenne, P T Klouda, B A Bradley.   

Abstract

Serologic analysis of two families identified an HLA-DR haplotype in which DR1 and DR2 cosegregated. DNA-RFLP analysis of these families with an HLA-DRB probe revealed a pattern of hybridization suggestive of a recombination between DR1 and DR15. Following amplification, cloning, and nucleotide sequencing of HLA-DRB-gene second-exon DNA sequences, three DRB amplification products associated with the novel haplotype were identified: these corresponded to DRB1*0101, DR2 pseudogene, and DRB5*0101. Clones representing the DRB1*1501 and DR1 pseudogenes were not identified: oligonucleotide typing with DRB1*1501-specific probes confirmed the absence of this gene within the DR1/DR2 haplotype. We postulate that the DR1/DR2 haplotype represents a recombinant between those of DR1-Dw1 and DR15-Dw2, and that the crossing-over may have been between the DRB1*0101 gene and the DR2 pseudogene. This is further supported by DNA-RFLP analysis with HLA-DQB and DQA CDNA probes, which revealed conserved linkage genes between the DQB1*0501, DQA1*0101, and DRB1*0101 genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353488     DOI: 10.1016/0198-8859(92)90337-m

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  A study of DR2-LUM haplotype generation and the DRB6*0202 linkage to DRB1*1601.

Authors:  A Corell; P Varela; P Morales; E Paz-Artal; J Martínez-Laso; J M Martín-Villa; E du Toit; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population.

Authors:  I Buyse; L A Sandkuyl; M Zamani Ghabanbasani; X X Gu; R Bouillon; M Bex; L Dooms; M P Emonds; M Duhamel; P Marynen
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.